Advertisements


Product name:Nilotinib
Price: | US$ 4300 / Kilogram |
---|---|
Minimum Order: | 100g |
Payment Terms: | Western Union, Moneygram,Bitcoin,Bank Wire |
Port of Export: | HongKong |
Product Details
Model No.: | Brand Name: | Zhuhai Wumei |
---|
Certification: | ISO9001 |
---|---|
Specification: | 500g/bag |
Packaging & Delivery
Packaging: | we use discreet and safe package, we also provide customized package |
---|---|
Delivery/Lead Time: | 7 to 12 days |
Production Capacity: | 50~100kg/month |
Product Description
Product name: Nilotinib
Synonyms: Nilotinib;AMN 107;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide;Nilotinib(TINIBS );4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide;Nilotinib for research;Tasigna
CAS: 641571-10-0
MF: C28H22F3N7O
MW: 529.52
Product Categories: API;Molecular Targeted Antineoplastic;Nucleotides and Nucleosides;Bases & Related Reagents;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;Pharmaceutical intermediate;AMN-107;Cardiovascular APIs;Inhibitors.
The treatment drug for the new chronic myelogenous leukemia (CML) Nilotinib is a novel drug for targeted cancer therapy and belongs to tyrosine kinase inhibitors for the treatment of patients of chronic myelogenous leukemia (CML) which is resistant to the Gleevec (imatinib) with an excellent efficacy.
SUPPLIER PROFILE
|
|||
---|---|---|---|
Company: | Zhuhai Wumei Technology Co., Ltd. | ||
City/State | Zhuhai, Guangdong | Country: |
China ![]() |
Business Type: | Export - Manufacturer / Trading Company | Established: | 2009 |
Member Since: | 2018 | Contact Person | Jack Song |
SUPPLIER PROFILE
City/State/Country -
Zhuhai, Guangdong
China 

Business Type -
Export - Manufacturer / Trading Company
Established -
2009
Member Since -
2018
Contact Person -
Jack Song